Healthy Extracts Inc. (HYEX)
- Previous Close
3.0000 - Open
3.0000 - Bid 2.4200 x 40000
- Ask 3.2500 x 40000
- Day's Range
2.5000 - 3.0000 - 52 Week Range
0.9106 - 4.2900 - Volume
499 - Avg. Volume
240 - Market Cap (intraday)
8.938M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Healthy Extracts Inc., through its subsidiaries, engages in the acquiring, developing, patenting, marketing, and distribution of plant-based nutraceuticals in the United States. It operates through two segments: Corporate and Health Supplements. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that improves brain health, including memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.
www.healthyextractsinc.com2
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: HYEX
View MorePerformance Overview: HYEX
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HYEX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HYEX
View MoreValuation Measures
Market Cap
8.94M
Enterprise Value
9.77M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.86
Price/Book (mrq)
21.78
Enterprise Value/Revenue
3.14
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.27%
Return on Assets (ttm)
-5.73%
Return on Equity (ttm)
-356.60%
Revenue (ttm)
3.36M
Net Income Avi to Common (ttm)
-378.27k
Diluted EPS (ttm)
-0.2800
Balance Sheet and Cash Flow
Total Cash (mrq)
118.8k
Total Debt/Equity (mrq)
1,779.25%
Levered Free Cash Flow (ttm)
449.43k